Specific inhibition of pathological prion protein accumulation by small interfering RNAs

Related Experiment Video

Updated: Sep 21, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Nathalie Daude1, Mathieu Marella, Joelle Chabry

  • 1Institut de Pharmacologie Moléculaire et Cellulaire, Unité Mixte de Recherche 6097, Centre National de la Recherche Scientifique. 660, route des lucioles, 06560 Valbonne, France.

Journal of Cell Science
|May 22, 2003
PubMed

Insights

Small interfering RNA (siRNA) effectively silences the prion protein gene (Prnp) in scrapie-infected cells. This approach reduces pathological prion protein (PrP-res) levels, offering a potential therapeutic strategy for prion diseases.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Transmissible spongiform encephalopathies (TSEs) pathogenesis depends on host prion protein (PrP-sen) and pathological PrP-res.
  • PrP-res aggregates convert normal PrP-sen into pathological forms, driving disease progression.

Purpose of the Study:

  • To investigate the efficacy of small interfering RNA (siRNA) for Prnp gene silencing in prion disease models.
  • To assess the impact of siRNA-mediated gene silencing on PrP-sen and PrP-res levels in infected cells.

Main Methods:

  • Transfection of scrapie-infected neuroblastoma cells with specific siRNA duplexes targeting the Prnp gene.
  • Quantification of PrP-sen and PrP-res levels post-transfection.
  • Assessment of siRNA cellular uptake and cytotoxicity.

Main Results:

  • siRNA successfully silenced the Prnp gene in scrapie-infected cells, leading to depletion of PrP-sen.
  • A rapid and significant reduction in PrP-res content was observed in transfected cells.
  • siRNA-induced gene silencing was efficient across different scrapie strains and host cells, with over 80% transfection efficiency and no observed cytotoxicity.

Conclusions:

  • siRNA-mediated Prnp gene silencing is a potent strategy for reducing prion protein accumulation.
  • The observed transient abrogation of PrP-res accumulation suggests siRNA as a promising therapeutic avenue for prion diseases.

More Related Videos

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Prion Safety Laboratory Swipe Test06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...